Alterity Therapeutics (ATHE) Other Non-Current Assets (2009 - 2016)

Alterity Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $32998.0 for Q4 2016.

• In Q4 2016, Other Non-Current Assets rose 0.85% year-over-year to $32998.0; the TTM figure through Dec 2016 stood at $32998.0 (up 0.85% YoY), while the FY2016 annual figure was $32998.0, changed N/A from the prior year.
• Other Non-Current Assets was $32998.0 for Q4 2016 at Alterity Therapeutics, roughly flat from $32845.9 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $43988.0 in Q4 2014 to a low of $32718.6 in Q4 2015.
• Historically, Other Non-Current Assets has averaged $36021.5 across 4 years, with a median of $34170.6 in 2015.
• The sharpest annual moves came in 2015 and 2016: Other Non-Current Assets decreased 25.62% in 2015, then grew 0.85% in 2016.
• A 4-year view of Other Non-Current Assets shows it stood at $38235.6 in 2012, then advanced by 15.04% to $43988.0 in 2014, then decreased by 25.62% to $32718.6 in 2015, then climbed by 0.85% to $32998.0 in 2016.
• The last three Other Non-Current Assets figures came in at $32998.0 (Q4 2016), $32845.9 (Q2 2016), and $32718.6 (Q4 2015), per Business Quant data.